CEO of Paradigm Health.“Through this partnership with CEORT, we're creating a system that connects clinical trials with the populations that need them most. From effective trial design to ...

Valuation wise, Paradigm Biopharmaceuticals (ASX:PAR) is what Winston Churchill referred to as a riddle wrapped in a mystery ...

James Fleming tells Verdict how The Francis Crick Institute is bringing together UK research data on a single data platform ...

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our ...

When it came time for a lead investor in PeopleOne Health's Series B funding, the Pittsburgh-based health firm reeled in a ...

Many hurdles stand in the way of successful innovation. The case of Zipline, an autonomous drone delivery platform, ...

Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like infection and inflammation. Intracameral drug delivery during surgery offers ...

Many countries, affluent or impoverished, use the Opportunity Economy in a flexible way to meet their national economic and ...

Followed categories will be added to My News. Paradigm Biopharmaceuticals says it is ready to apply to the US regulator to start its delayed phase III trial for knee osteoarthritis AFT ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...